Your browser doesn't support javascript.
loading
Structures of carboxylic acid reductase reveal domain dynamics underlying catalysis.
Gahloth, Deepankar; Dunstan, Mark S; Quaglia, Daniela; Klumbys, Evaldas; Lockhart-Cairns, Michael P; Hill, Andrew M; Derrington, Sasha R; Scrutton, Nigel S; Turner, Nicholas J; Leys, David.
Afiliação
  • Gahloth D; Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
  • Dunstan MS; Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
  • Quaglia D; Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
  • Klumbys E; Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
  • Lockhart-Cairns MP; Division of Cell Matrix Biology and Regenerative Medicine, School of Biological Sciences, University of Manchester, Manchester, UK.
  • Hill AM; Diamond Light Source, Harwell Science and Innovation Campus, Didcot, UK.
  • Derrington SR; Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
  • Scrutton NS; Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
  • Turner NJ; Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
  • Leys D; Manchester Institute of Biotechnology, School of Chemistry, University of Manchester, Manchester, UK.
Nat Chem Biol ; 13(9): 975-981, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28719588
Carboxylic acid reductase (CAR) catalyzes the ATP- and NADPH-dependent reduction of carboxylic acids to the corresponding aldehydes. The enzyme is related to the nonribosomal peptide synthetases, consisting of an adenylation domain fused via a peptidyl carrier protein (PCP) to a reductase termination domain. Crystal structures of the CAR adenylation-PCP didomain demonstrate that large-scale domain motions occur between the adenylation and thiolation states. Crystal structures of the PCP-reductase didomain reveal that phosphopantetheine binding alters the orientation of a key Asp, resulting in a productive orientation of the bound nicotinamide. This ensures that further reduction of the aldehyde product does not occur. Combining crystallography with small-angle X-ray scattering (SAXS), we propose that molecular interactions between initiation and termination domains are limited to competing PCP docking sites. This theory is supported by the fact that (R)-pantetheine can support CAR activity for mixtures of the isolated domains. Our model suggests directions for further development of CAR as a biocatalyst.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxirredutases / Domínio Catalítico Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxirredutases / Domínio Catalítico Idioma: En Ano de publicação: 2017 Tipo de documento: Article